Literature DB >> 7616747

Clinical development plan: sulindac.

G J Kelloff1, J A Crowell, C W Boone, V E Steele, R A Lubet, P Greenwald, D S Alberts, J M Covey, L A Doody, G G Knapp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7616747

Source DB:  PubMed          Journal:  J Cell Biochem Suppl        ISSN： 0733-1959


× No keyword cloud information.
  3 in total

Review 1.  Lung cancer. 1: prevention of lung cancer.

Authors:  G E Goodman
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

2.  Comparative bioavailability of sulindac in capsule and tablet formulations.

Authors:  Joel M Reid; Sumithra J Mandrekar; Elsa C Carlson; W Scott Harmsen; Erin M Green; Renee M McGovern; Eva Szabo; Matthew M Ames; Daniel Boring; Paul J Limburg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

Review 3.  Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives.

Authors:  Altaf Mohammed; Nagendra Sastry Yarla; Venkateshwar Madka; Chinthalapally V Rao
Journal:  Int J Mol Sci       Date:  2018-08-08       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.